Vitespen Completed Phase 3 Trials for Renal Cell Adenocarcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00033904Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer